These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12891179)

  • 1. Low molecular weight heparins for acute coronary syndrome: tackling the issues head-on.
    Antman EM
    Am Heart J; 2003 Aug; 146(2):191-3. PubMed ID: 12891179
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of low-molecular-weight heparin in unstable angina, acute myocardial infarction and post-elective percutaneous transluminal coronary angioplasty].
    Pimentel Filho WA
    Arq Bras Cardiol; 1995 Dec; 65(6):517-8. PubMed ID: 8731307
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-molecular-weight heparins for the treatment of acute coronary syndromes.
    Wong GC; Giugliano RP
    Semin Vasc Med; 2003 Nov; 3(4):391-402. PubMed ID: 15199446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease.
    Krulewitz A
    N Engl J Med; 1998 Jan; 338(2):130; author reply 131. PubMed ID: 9424584
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease.
    Goodall AH; Knight C
    N Engl J Med; 1998 Jan; 338(2):130-1. PubMed ID: 9424585
    [No Abstract]   [Full Text] [Related]  

  • 6. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
    Haas S
    Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of low-molecular-weight heparins in the treatment of acute coronary syndrome].
    Carlsson J; Tebbe U
    Dtsch Med Wochenschr; 2002 Apr; 127(16):859-65. PubMed ID: 11961704
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and evaluation committees' methods for appraising new drugs. Committee failed to meet aims in producing report on low molecular weight heparins.
    Bosanquet N; Fox K
    BMJ; 2000 Mar; 320(7236):714-5. PubMed ID: 10710594
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-molecular weight heparins.
    Talley JD
    J Ark Med Soc; 1997 Apr; 93(11):555-6. PubMed ID: 9114648
    [No Abstract]   [Full Text] [Related]  

  • 10. Low molecular weight heparins in the treatment of unstable angina.
    Ageno W; Turpie AG
    Minerva Cardioangiol; 2002 Dec; 50(6):643-51. PubMed ID: 12473984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes.
    Rosito GA; Silva OB; Ribeiro JP
    Arq Bras Cardiol; 2001 Aug; 77(2):184-95. PubMed ID: 11514830
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reliable anticoagulation in acute myocardial infarction. Acute coronary syndromes: advances with low-molecular heparin therapy].
    Z Kardiol; 1998 Dec; 87(12 Suppl Akute Koro):1-4. PubMed ID: 9884738
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of low-molecular-weight heparin in acute coronary syndromes].
    Gharbi M; Barakett N; Lahidheb DH; Smiri Z; Fehri W; Azzouzi F; Rahal N; Mhenni H; Haouala H; Guediche M
    Tunis Med; 2002 Dec; 80(12):725-32. PubMed ID: 12664498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparins for unstable angina. A better mousetrap?
    Waters D; Azar RR
    Circulation; 1997 Jul; 96(1):3-5. PubMed ID: 9236404
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease.
    Kearon C
    N Engl J Med; 1998 Jan; 338(2):129-30; author reply 131. PubMed ID: 9424582
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulants in coronary artery disease.
    Lee LV
    Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparins: their established role in acute coronary syndromes and perspectives in atrial fibrillation.
    Melandri G; Nanni S; Tricoci P; Melloni C; Semprini F; Fallani F; Bracchetti G; Branzi A
    Haematologica; 2001 Nov; 86(11 Suppl 2):54-7. PubMed ID: 11926779
    [No Abstract]   [Full Text] [Related]  

  • 19. [Non-fractionated heparin versus low molecular weight heparin in acute coronary syndromes].
    González Pacheco H
    Arch Cardiol Mex; 2001; 71 Suppl 1():S63-8. PubMed ID: 11565348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining treatment strategies in the 21st century: low-molecular-weight heparins in acute coronary syndromes.
    Zidar JP
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():16B-21B. PubMed ID: 10731295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.